Cancer Council NSW researchers have estimated the benefits, harms and cost-effectiveness.
Research we are currently funding:
The outcomes of this new study will be the identification of key players involved in the function of a protein called MCC and how they could be targeted in cancer treatment.
This multinational randomised trial is the first randomised study of aspirin for cancer survival and could result in a change of practice across the world.
This research will be used to study myeloma in the early stages to see whether normal bone cells switch on these dormant cells and cause the cancer to grow.
Bowel cancer development is driven by a molecular network that helps the cancer cells to grow and survive. Professor Zhang are exploring whether this network could be targeted and blocked.